Garsubellin A with a cyclohexanone skeleton is a potent inducer of choline acetyltransferase (ChAT) and could be used for the treatment of Alzheimer's disease [3–4]. The gene discussed is CHAT; the disease is early-onset autosomal dominant Alzheimer disease.